资源类型:
会议/期刊
收录情况:
◇ SCIE
文章类型:
会议摘要
作者:
Feinstein, T.[1]
*
;
Han, B.[2]
;
Shi, Y.[3]
;
Chen, G.[4]
;
Yao, Y.[5]
;
Hu, C.[6]
;
Shi, J.[7]
;
Feng, J.[8]
;
Wu, H.[9]
;
Chen, Y.[10]
;
Guo, Q-S.[11]
;
Jie, Z.[12]
;
Ye, F.[13]
;
Zhang, Y.[14]
;
Liu, Z.[15]
;
Mao, W.[16]
;
Zhang, L.[17]
;
Lu, J.[18]
;
Zhao, J.[19]
;
Bazhenova, L.[20]
;
Ruiz, J.[21]
;
Kloecker, G.[22]
;
Kalmadi, S.[23]
;
Oliff, I.[24]
;
Wong, M.[25]
;
Liu, B.[26]
;
Wu, Y.[26]
;
Huang, L.[27]
;
Sun, Y.[28]
;
Luo, F.[29]
;
Zhou, J-Y.[30]
;
Pan, H.[31]
;
Wang, H.[32]
;
Liu, C.[33]
;
Cao, L.[34]
;
Huang, C.[35]
;
Thara, E.[36]
;
Li, X.[37]
;
Jiang, D.[38]
;
Mowat, R. B.[39]
;
Hrom, J. S.[40]
;
Nagrial, A.[41]
;
Jain, V.[42]
;
Karim, N. A.[43]
;
Shunyakov, L. V.[44]
;
Kiberu, A.[45]
;
Jennens, R.[46]
;
Lloyd, K.[27]
;
Wang, Z.[26]
;
Du, L.[26]
;
机构:
[1]Piedmont Canc Inst, Atlanta, GA USA
[2]Shanghai Chest Hosp, Shanghai, Peoples R China
[3]Chinese Acad Med Sci, Canc Hosp, Beijing, Peoples R China
[4]Harbin Med Univ, Affiliated Canc Hosp, Harbin, Peoples R China
[5]Xi An Jiao Tong Univ, Affiliated Hosp 1, Coll Med, Xian, Peoples R China
[6]Cent South Univ, Xiangya Hosp 2, Changsha, Hunan, Peoples R China
[7]Linyi Canc Hosp, Linyi, Shandong, Peoples R China
[8]Jiangsu Canc Hosp, Nanjing, Peoples R China
[9]Henan Canc Hosp, Zhengzhou, Peoples R China
河南省肿瘤医院
[10]Jilin Canc Hosp, Changchun, Peoples R China
[11]Shandong Canc Hosp & Inst, Jinan, Peoples R China
[12]Fudan Univ, Peoples Hosp 5, Shanghai, Peoples R China
[13]Xiamen Univ, Affiliated Hosp 1, Xiamen, Peoples R China
[14]Zhejiang Canc Hosp, Hangzhou, Peoples R China
浙江省肿瘤医院
[15]Jiangxi Canc Hosp, Nanchang, Jiangxi, Peoples R China
[16]Jiangyin Peoples Hosp, Wuxi, Jiangsu, Peoples R China
[17]Yantai Yuhuangding Hosp, Yantai, Peoples R China
[18]Nantong Tumor Hosp, Tongzhou, Peoples R China
[19]Beijing Canc Hosp, Beijing, Peoples R China
[20]Univ Calif San Diego, Moores Canc Ctr, San Diego, CA USA
[21]Wake Forest Univ Hlth Syst, Salisbury, NC USA
[22]Univ Louisville Hosp, Louisville, KY USA
[23]Ironwood Canc & Res Ctr PC, Chandler, AZ USA
[24]Orchard Healthcare Res Inc, Skokie, IL USA
[25]Gosford Hosp, Gosford, Australia
[26]BeyondSpring Pharmaceut, Dalian, Peoples R China
[27]BeyondSpring Pharmaceut, New Jersey, NJ USA
[28]Beijing Tumor Hosp, Dept Pulm Med, Natl Acad Sci, Beijing, Peoples R China
[29]Sichuan Univ, West China Hosp, Chengdu, Peoples R China
四川大学华西医院
[30]Zhejiang Univ, Sch Med, Affiliated Hosp 1, Hangzhou, Peoples R China
浙江大学医学院附属第一医院
[31]Zhejiang Univ, Sir Run Run Hosp, Hangzhou, Peoples R China
[32]Tianjin Union Med Hosp, Tianjin, Peoples R China
[33]Xinjiang Med Univ, Affiliated Tumor Hosp, Urumqi, Peoples R China
[34]Anhui Prov Hosp, Hefei, Peoples R China
[35]Univ Kansas, Ctr Canc, Westwood, KS USA
[36]hInnovat Clin Res Inst, Long Beach, CA USA
[37]Liaoning Canc Hosp & Inst, Shenyang, Peoples R China
[38]Hebei Med Univ, Hosp 4, Shijiazhuang, Hebei, Peoples R China
河北医科大学第四医院
肿瘤内科
临床科室
[39]Toledo Clin Canc Cente, Toledo, OH USA
[40]Hattiesburg Clin, Hematol Oncol, Hattiesburg, MS USA
[41]Blacktown Canc & Haematol Ctr, Blacktown, NSW, Australia
[42]Mater Canc Care Ctr, Brisbane, Qld, Australia
[43]Univ Cincinnati, Inst Canc, Fairfax, VA USA
[44]Cent Care Canc Ctr, Bolivar, MO USA
[45]Fiona Stanley Hosp, Ctr Canc, Murdoch, WA, Australia
[46]Epworth Med Fdn, Richmond, Vic, Australia
出处:
JOURNAL OF THORACIC ONCOLOGY.2024,19(10):S24-S25.
ISSN:
1556-0864
WOS:
WOS:001337925600039
中科院分区:
出版当年[2025]版:
大类
|
1 区
医学
小类
|
1 区
肿瘤学
1 区
呼吸系统
最新[2025]版:
大类
|
1 区
医学
小类
|
1 区
肿瘤学
1 区
呼吸系统
JCR分区:
出版当年[2024]版:
Q1
ONCOLOGY
Q1
RESPIRATORY SYSTEM
最新[2024]版:
Q1
ONCOLOGY
Q1
RESPIRATORY SYSTEM
影响因子:
20.8
最新[2024版]
18.4
最新五年平均
20.8
出版当年[2024版]
18.4
出版当年五年平均
21.1
出版前一年[2023版]
第一作者:
Feinstein, T.
第一作者机构:
[1]Piedmont Canc Inst, Atlanta, GA USA
推荐引用方式(GB/T 7714):
Feinstein T.,Han B.,Shi Y.,et al.Plinabulin/Docetaxel vs. Docetaxel in 2L/3L NSCLC after Platinum Regimens (DUBLIN-3): A Phase 3 Randomized Controlled Trial[J].JOURNAL OF THORACIC ONCOLOGY.2024,19(10):S24-S25.
APA:
Feinstein, T.,Han, B.,Shi, Y.,Chen, G.,Yao, Y....&Du, L..(2024).Plinabulin/Docetaxel vs. Docetaxel in 2L/3L NSCLC after Platinum Regimens (DUBLIN-3): A Phase 3 Randomized Controlled Trial.JOURNAL OF THORACIC ONCOLOGY,19,(10)
MLA:
Feinstein, T.,et al."Plinabulin/Docetaxel vs. Docetaxel in 2L/3L NSCLC after Platinum Regimens (DUBLIN-3): A Phase 3 Randomized Controlled Trial".JOURNAL OF THORACIC ONCOLOGY 19..10(2024):S24-S25